BioMarker Strategies LLC - Product Pipeline Analysis, 2019 Update
October 2019
32
About the Report
About the Report
Summary
BioMarker Strategies LLC (BioMarker Strategies) is a biotechnology company that develops tissue-based cancer diagnostic systems. The company offers cancer diagnostics system for predictive tests to targeted treatments for solid tumor malignancies. It also offers pathmap functional signaling profiles, a class of biomarker tests. BioMarker Strategies' snappath is used for predictive tests to guide targeted drug development and treatment selection. The company's pathmap profiles provide predictive tests to guid targeted drug development, information on signal transduction networks, which include pathway activation and feedback loops that predicts patient response to targeted drug therapy. Its products are used in early clinical studies for assessing pharmacodynamic changes in the solid tumors. BioMarker Strategies is headquartered in Rockville, Maryland, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BioMarker Strategies LLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
BioMarker Strategies LLC, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Ventana Medical Systems Inc
AnalizaDx LLC
Dako North America Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
BioMarker Strategies LLC Company Overview
BioMarker Strategies LLC Company Snapshot
BioMarker Strategies LLC Pipeline Products and Ongoing Clinical Trials Overview
BioMarker Strategies LLC-Pipeline Analysis Overview
BioMarker Strategies LLC-Key Facts
BioMarker Strategies LLC-Major Products and Services
BioMarker Strategies LLC Pipeline Products by Development Stage
BioMarker Strategies LLC Pipeline Products Overview
Companion Diagnostic Test-HNSCC
Companion Diagnostic Test-HNSCC Product Overview
Ex Vivo Biomarker Test-Breast Cancer
Ex Vivo Biomarker Test-Breast Cancer Product Overview
Ex Vivo Biomarker Test-Colon Cancer
Ex Vivo Biomarker Test-Colon Cancer Product Overview
Ex Vivo Biomarker Test-Lung Cancer
Ex Vivo Biomarker Test-Lung Cancer Product Overview
Ex Vivo Biomarker Test-Melanoma
Ex Vivo Biomarker Test-Melanoma Product Overview
Ex Vivo Biomarker Test-Pancreatic Cancer
Ex Vivo Biomarker Test-Pancreatic Cancer Product Overview
Ex Vivo Biomarker Test-Solid Tumors
Ex Vivo Biomarker Test-Solid Tumors Product Overview
PathMAP-Melanoma
PathMAP-Melanoma Product Overview
PathMAP NSCLC
PathMAP NSCLC Product Overview
BioMarker Strategies LLC-Key Competitors
BioMarker Strategies LLC-Key Employees
BioMarker Strategies LLC-Locations And Subsidiaries
Head Office
Recent Developments
BioMarker Strategies LLC, Recent Developments
Jun 03, 2019: BioMarker Strategies announces that both of its core diagnostics technologies for solid tumor cancers are now covered by patents granted in Korea
Jun 02, 2019: BioMarker Strategies to present at the BIO 2019 International Convention in Philadelphia
Jun 04, 2018: BioMarker Strategies announces Chinese patent for PathMAP functional signaling profile technology
Mar 28, 2018: BioMarker Strategies Announces that Both of Its Core Diagnostics Technologies for Solid Tumor Cancers Are Now Covered by New Patents Granted in Canada
Oct 03, 2017: BioMarker Strategies Announces Phase I National Cancer Institute Grant to Develop Companion Diagnostic to Identify Patients with Head and Neck Cancer Who Are Most Likely to Respond to Treatment with Cetuximab
Sep 25, 2017: BioMarker Strategies Announces United States Patent for PathMAP Functional Signaling Profile Technology
Sep 11, 2017: BioMarker Strategies Announces Phase II National Cancer Institute Grant to Continue Development of Companion Diagnostic Test to Help Select Optimal Therapy for Patients with Non-Small Cell Lung Cancer
Aug 31, 2017: BioMarker Strategies Announces Two New Patents Granted in Japan, For the Company's Core Diagnostics Technology PathMAP
Jul 19, 2017: BioMarker Strategies Announces Issuance of Key Patent in Europe Covering the Company's PathMAP Functional Signaling Profile Technology
Sep 19, 2016: BioMarker Strategies Awarded Phase I National Cancer Institute Contract to Develop Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
BioMarker Strategies LLC Pipeline Products by Equipment Type
BioMarker Strategies LLC Pipeline Products by Development Stage
List of Table
List of Tables
BioMarker Strategies LLC Pipeline Products and Ongoing Clinical Trials Overview
BioMarker Strategies LLC Pipeline Products by Equipment Type
BioMarker Strategies LLC Pipeline Products by Indication
BioMarker Strategies LLC, Key Facts
BioMarker Strategies LLC, Major Products and Services
BioMarker Strategies LLC Number of Pipeline Products by Development Stage
BioMarker Strategies LLC Pipeline Products Summary by Development Stage
Companion Diagnostic Test-HNSCC-Product Status
Companion Diagnostic Test-HNSCC-Product Description
Ex Vivo Biomarker Test-Breast Cancer-Product Status
Ex Vivo Biomarker Test-Breast Cancer-Product Description
Ex Vivo Biomarker Test-Colon Cancer-Product Status
Ex Vivo Biomarker Test-Colon Cancer-Product Description
Ex Vivo Biomarker Test-Lung Cancer-Product Status
Ex Vivo Biomarker Test-Lung Cancer-Product Description
Ex Vivo Biomarker Test-Melanoma-Product Status
Ex Vivo Biomarker Test-Melanoma-Product Description
Ex Vivo Biomarker Test-Pancreatic Cancer-Product Status
Ex Vivo Biomarker Test-Pancreatic Cancer-Product Description
Ex Vivo Biomarker Test-Solid Tumors-Product Status
Ex Vivo Biomarker Test-Solid Tumors-Product Description
PathMAP-Melanoma-Product Status
PathMAP-Melanoma-Product Description
PathMAP NSCLC-Product Status
PathMAP NSCLC-Product Description
BioMarker Strategies LLC, Key Employees
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.